Dr. Fanny Elahi on Alzheimer's Research, Blood Biomarkers, and Women's Health

Alzheimer's Disease and Women's Vulnerability

• 🎯 Alzheimer's disease affects over 7 million Americans, with projections to nearly 13 million by 2050.
• 💡 While women are afflicted at a higher prevalence, the exact reasons for their increased vulnerability to Alzheimer's and other neurodegenerative disorders are still being researched.
• 🧠 Understanding why women's brains are more susceptible could unlock key factors that make aging brains vulnerable to Alzheimer's.

Hormonal Shifts and Brain Health

• ⚠️ A central hypothesis suggests that the physiological transition of menopause in midlife, marked by a shift in hormones like estrogen, significantly impacts women's brain health.
• 🔬 Research is querying the impact of lower estrogen levels on brain vasculature cells and protective barriers.
• ❓ Key questions remain about the optimal timing and duration for hormone replacement therapy to mitigate Alzheimer's risk without increasing other health risks like cancer.

Genetic Factors and Heritability

• 🧬 The APOE E4 allele is a prevalent genetic risk factor for Alzheimer's, and it is thought to interact with hormones.
• 🧬 Heritability of Alzheimer's extends beyond APOE E4, potentially involving inherited aspects of metabolism and mitochondria, particularly from the maternal side.
• 🔍 Further research into ancestry and its influence on disease susceptibility is ongoing.

The Promise of Blood Biomarkers

• ⚡ Blood biomarkers are crucial for detecting neurodegenerative diseases like Alzheimer's before prominent symptoms like cognitive impairment appear.
• 📈 These biomarkers can detect the risk of future symptoms with increasing predictive ability, as the underlying pathologies often begin decades before symptom onset.
• 🔬 Current research aims to expand biomarker panels to include detection of vascular pathologies in the brain, for which precise biomarkers are currently lacking.

Optimism for Future Breakthroughs

• 🚀 There is significant optimism for major breakthroughs in Alzheimer's treatment and prevention within the coming decade.
• ✅ Two FDA-approved treatments already exist that slow disease progression, with many more promising treatments in the pipeline.